We have investigated the isotypic and IgG subclass profile of the antibody response to HTLV-
I structural proteins (gag and env) in patients with HTLV-I-associated myelopathy (HAM; n …

Eighteen long-term T-cell lines were established from peripheral blood mononuclear cells of
individuals infected with human T-lymphotropic virus type I (HTLV-I) or II (HTLV-II). These …

A new algorithm based upon the differential antibody responses to two gag gene products
(p19 and p24) of human T lymphotropic virus (HTLV) has been suggested for serologic …

We have characterized the immunoreactivity to human T-cell lymphotropic virus type I (HTLV-
I) among 26,983 persons of various seroprevalence groups by using enzyme immunoassay …

Synthetic peptide‐based serologic assays (Select‐HTLV and SynthEIA) that distinguish the
closely related human T‐cell lymphotropic virus types I (HTLV‐I) and II (HTLV‐II) were tested …

The immunoglobulin (Ig) isotypes of antibodies to specific proteins of the human T cell
lymphotropic virus type I (HTLV-I) were determined by Western blot analysis of serial …

An immunodominant HTLV-I-specific epitope in the HTLV-I envelope glycoprotein (GP) 46
has been described. To determine if the analogous region of HTLV-II contains a similarly …

A series of synthetic peptides derived from the envelope glycoprotein of human T
lymphotropic virus type II (HTLV-II) was used in an enzyme immunoassay to determine the …

In November 1988, the Food and Drug Administration approved reagents for serologic
screening for human T‐lymphotropic virus type I (HTLV‐I) infection in blood donors and …

We compared the sensitivities of the prototype human T-cell lymphotropic virus type I (HTLV-
I)-and HTLV-II-transformed cell lines, MT2 and Mo-T, with that of an HTLV-II-infected cell …